- Report
- July 2024
- 187 Pages
Global
From €3932EUR$4,450USD£3,443GBP
- Report
- August 2024
- 200 Pages
Global
From €3932EUR$4,450USD£3,443GBP
- Report
- July 2023
- 220 Pages
From €3049EUR$3,450USD£2,669GBP
- Report
- July 2023
- 224 Pages
North America
From €3049EUR$3,450USD£2,669GBP
- Report
- July 2023
- 230 Pages
Africa, Middle East
From €3049EUR$3,450USD£2,669GBP
- Report
- July 2023
- 253 Pages
Europe
From €3049EUR$3,450USD£2,669GBP
- Report
- June 2023
- 250 Pages
Asia Pacific
From €3049EUR$3,450USD£2,669GBP
- Report
- December 2022
- 83 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- April 2022
- 64 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- February 2022
- 50 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- January 2024
- 150 Pages
Global
From €3402EUR$3,850USD£2,979GBP
€4286EUR$4,850USD£3,752GBP
- Report
- April 2023
- 150 Pages
Global
From €3402EUR$3,850USD£2,979GBP
€4286EUR$4,850USD£3,752GBP
- Report
- January 2024
- 110 Pages
Global
From €3977EUR$4,500USD£3,481GBP
- Report
- August 2024
- 200 Pages
Global
From €4373EUR$4,949USD£3,829GBP
- Report
- May 2023
- 140 Pages
Global
From €4373EUR$4,949USD£3,829GBP
- Report
- April 2024
- 121 Pages
Global
From €3491EUR$3,950USD£3,056GBP
- Report
- March 2023
- 346 Pages
Global
From €3932EUR$4,450USD£3,443GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3419EUR$3,869USD£2,993GBP
- Report
- May 2024
- 140 Pages
Global
From €4373EUR$4,949USD£3,829GBP
- Report
- May 2023
- 147 Pages
Global
From €4373EUR$4,949USD£3,829GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more